Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 210 posts found.

Blow for Irish pharma sector as Teva, Elan cut staff

September 7, 2009
Manufacturing and Production Elan, Teva, lilly

Ireland’s pharmaceutical sector suffered a double blow last week as two drugmakers opted to make staff redundant at manufacturing plants …

News

Effient approved in US

July 17, 2009
Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …

News

US approval boosts Plavix competitor

July 14, 2009
Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …

News

Lilly invites researchers to submit novel compounds online

June 16, 2009
Medical Communications, Research and Development digi, lilly

Lilly is launching a new web portal which it hopes will attract drug discovery researchers with promising new compounds. The …

News

Efient launched in the UK

April 9, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …

News

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009
Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …

News

Europe approves Lilly’s Plavix rival

February 25, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

News

Lilly to reduce pipeline costs by a third

December 17, 2008
Research and Development lilly, restructure

Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …

News

Companies try to quell rumours on prasugrel

October 17, 2008
Sales and Marketing Efient, lilly

Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …

News

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

News

Long-acting Zyprexa gets green light

October 2, 2008
Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …

News

Lilly unveils streamlined business structure

May 22, 2008
Sales and Marketing lilly, restructure

A simplified and slimmed-down corporate structure has been unveiled by US pharmaceutical firm Lilly, which says it hopes to cut …

News

Lechleiter to be new Lilly chief

January 3, 2008
Sales and Marketing lilly

 John Lechleiter, Lilly's current president and chief operating officer has been named as the company's next chief executive.Sidney Taurel is …

News

New products behind Lilly growth

October 19, 2007
Sales and Marketing lilly, zyprexa

Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …

News

Secrets of a youthful brand

April 12, 2005
Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …

Feature

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024